Essam J. Alyamani received the Ph.D. degree in pharmaceutical/medical sciences majoring in molecular bacteriology from Northeastern University, Boston, MA, USA, in 2006. He completed postdoctoral research programs in nanomedicine and bacterial genetics at Northwestern University, Chicago, and Ottawa University, Ottawa, ON, Canada. He worked in biotechnology at the National Center for Biotechnology, KACST. His laboratory aims to study and understand the prevalence of antimicrobial drug resistance and the mechanisms of gene evolution responsible for antimicrobial resistance in Saudi Arabia. He investigated highly antibiotic-resistant gram-negative bacteria (i.e., Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae) to characterize and identify their clonal lineages for epidemiological tracing to minimize their spread. He aims to develop new diagnostic tools or vaccines for bacterial infectious diseases in animals or humans by genomic approaches. His research interests include bacterial pathogenesis, resistome, and microbial biotechnology applications.